COVID-19 study- Novel blood markers as future diagnostic & therapeutic targets
23 Aug 2022 //
GLOBENEWSWIRE
Antisense Tx to present poster at world’s largest NMD conference
09 Mar 2022 //
GLOBENEWSWIRE
Antisense Therapeutics Announces a Poster Presentation on the MDA
11 Jun 2020 //
BUSINESSWIRE
Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint
21 May 2020 //
MARKETWATCH
Antisense ATL1102 Final Phase II DMD Results Meet Primary Endpoint
21 May 2020 //
BUSINESSWIRE
Positive results reaffirm plans to advance ATL1102 for DMD to Phase IIb trial
17 Dec 2019 //
BIO SPACE